🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
The purpose of this study is to evaluate the efficacy and safety of recombi...
Status
Not Yet Recruiting
Location
Air Force Military Medical University/ Fourth Military Medical University
Start Date
2022-09-30
Trial ID
NCT05539118
Treatments Being Tested
This study will evaluate the safety and efficacy of durvalumab in combinati...
Status
Unknown
Location
Multiple Locations
Start Date
2020-08-31
Trial ID
NCT04444193
Treatments Being Tested
Conventional biopsy and surgical tumor resection are invasive procedures th...
Status
Completed
Location
University General Hospital of Alexandroupoli
Start Date
2019-06-25
Trial ID
NCT04490564
Treatments Being Tested
This is a phase II, open-label study to evaluate the efficacy and safety of...
Status
Unknown
Location
the First Affiliated Hospital, School of Medicine, Zhejiang University
Start Date
2023-04
Trial ID
NCT05312216
Treatments Being Tested
Colorectal cancer (CRC) and pancreatic ductal adenocarcinoma (PDAC) are the...
Status
Completed
Location
Centre Léon Bérard
Start Date
2016-06
Trial ID
NCT02777710
Treatments Being Tested
In many cancers, early stage diagnosis and early treatment offers the best ...
Status
Active Not Recruiting
Location
Melanoma Institute Australia
Start Date
2020-11-11
Trial ID
NCT04207086
Treatments Being Tested
This is a phase 2, single-centre, randomized, multi-cohort trial of subject...
Status
Active Not Recruiting
Location
Princess Margaret Cancer Centre
Start Date
2019-04-08
Trial ID
NCT03851614
Treatments Being Tested
This phase II, multicenter, single-arm, open-label study evaluates first-li...
Status
Not Yet Recruiting
Location
West China Hospital, Chengdu, Sichuan 610000
Start Date
2026-08
Trial ID
NCT07715565
Treatments Being Tested
Multiple sclerosis (MS) is an autoimmune neurodegenerative disease characte...
Status
Unknown
Location
Multiple Locations
Start Date
2022-10-01
Trial ID
NCT05451069
Objective to compare the efficacy and safety of TQB2450 injection combined ...
Status
Recruiting
Location
The Central People's Hospital of Huizhou
Start Date
2023-04-12
Trial ID
NCT06141226
Treatments Being Tested